
What megalodon really ate to meet its 100,000-calorie daily requirement, according to a new study
CNN —
What scientists understand about the voracious feeding habits of the colossal megalodon could be up for some revision.
The prehistoric predator that went extinct about 3.6 million years ago was not hunting only large marine mammals such as whales as researchers widely thought, a new study has found. Instead, minerals in fossilized teeth reveal that megalodon might have been an opportunistic feeder to meet its remarkable 100,000-calorie-per-day requirement.
'When available, it would probably have fed on large prey items, but when not available, it was flexible enough to feed also on smaller animals to fulfill its dietary requirements,' said lead study author Jeremy McCormack, a geoscientist at Goethe University in Frankfurt, Germany.
The study, published Monday in the journal Earth and Planetary Science Letters, also showed there were regional differences in the giant shark's feeding habits. The finding suggests megalodon would pursue whatever was in local waters, devouring other top predators and smaller prey alike.
'They were not concentrating on certain prey types, but they must have fed throughout the food web, on many different species,' McCormack said. 'While certainly this was a fierce apex predator, and no one else would probably prey on an adult megalodon, it's clear that they themselves could potentially feed on almost everything else that swam around.'
Megalodon dispatched its prey with a ferocious bite and lethal, serrated teeth that could reach up to 7 inches (18 centimeters) long — the size of a human hand. The superpredator's teeth — abundant in the fossil record — are what McCormack and his colleagues used to conduct a geochemical analysis, unlocking fresh clues that could challenge megalodon's role as sole king of the ancient seas.
Zinc in megalodon teeth
It's not the first time that a study has challenged previous knowledge about the enormous sea creature. In fact, many questions remain unanswered about Otodus megalodon — its scientific species name meaning 'giant tooth' — since no complete fossil has ever been discovered. The lack of hard evidence stems from the fact that fish skeletons are made of softer cartilage rather than bone, so they don't fossilize very well.
Recent research found that the animal was more warm-blooded than other sharks, for example, and there is an ongoing debate about its size and shape. Scientists who created a 3D reconstruction suggest ed in 2022 that megalodon was about three times as long as a great white shark — about 52 feet (16 meters). However, a March study hypothesized that the megashark was actually much larger — up to 80 feet (24 meters) in length and even longer than the fictional version in the 2018 blockbuster 'The Meg,' which suggested the ancient predator was 75 feet (23 meters) from head to tail.
As for megalodon's feeding habits, determining what it ate based on fossil evidence poses challenges, according to McCormack. 'We know that they fed on large marine mammals from tooth bite marks,' he said. 'Of course, you can see bite marks on the bones of marine mammals, but you will not see them if they fed on other sharks, because sharks don't have bones. So there's already a bias in this kind of fossil record.'
To glean more about megalodon's prey selection, McCormack and his coauthors looked at the giant shark's fossilized teeth and compared them with those of other animals that lived at the same time, as well as teeth from modern sharks and other predators such as dolphins. The researchers used specimens from museum collections and samples from beached animal carcasses.
Specifically, the study team conducted a lab analysis of zinc, a mineral that is acquired only through food.
Zinc is essential for living organisms and plays a crucial role in tooth development. The ratio of heavy and light zinc isotopes in the sharks' tooth enamel preserves a record of the kind of animal matter that they ate.
Different types, or isotopes, of zinc are absorbed when fish and other animals eat, but one of them — zinc-66 — is stored in tooth enamel much less than another, zinc-64. The ratio between those zinc isotopes widens the further away an animal gets from the lowest level of the food chain. That means that a fish eating other fish would have lower levels of zinc-66 compared with zinc-64, and the fish that eat those fish will have even less zinc-66 compared with zinc-64, creating ratio markers that can help draw up a sequence of the food chain.
The researchers found that sea bream, a fish that feeds on mussels and crustaceans, was at the bottom of their reconstructed chain, followed by smaller sharks from the Carcharhinus genus, up to 9.8 feet (3 meters) in length, and extinct toothed whales comparable in size to modern dolphins.
Farther up were larger sharks such as the Galeocerdo aduncus, similar to a modern tiger shark, and occupying the top slot was megalodon — but its zinc ratios were not so different as to suggest a massive gap with the lower-tier animals, meaning they might have been part of megalodon's diet, too. 'Based on our new results, we see that it was clear it could feed at the very top, but it was flexible enough to feed also on lower (levels of the food chain),' McCormack said.
In addition, the researchers found megalodon was not alone at the top of the food chain but instead shared the spot with other 'opportunistic supercarnivores' such as its close relative Otodus chubutensis and the lesser-known Araloselachus cuspidatus, another giant fish-eating shark.
That revelation challenges the assumption that megalodon was the exclusive ruler of the oceans and draws comparisons with the great white shark, another large opportunistic feeder. The finding also reinforces the idea that the rise of the great white may have been a factor in megalodon's extinction, according to paleobiologist Kenshu Shimada, one of the coauthors of the latest study.
'One of the contributing factors for the demise of megalodon has been hypothesized to be the rise of the great white shark, which feeds on fish when young and shifts its diet to marine mammals as it becomes larger,' said Shimada, a professor of biological and environmental sciences at DePaul University in Chicago.
'Our new study, that demonstrates the 'diet overlap' between the great white shark and megalodon, strengthens the idea that the evolution of the smaller, likely more agile and maneuverable great white shark could have indeed (driven) megalodon to extinction.'
Megalodon vs. great white shark
The new research allows scientists to recreate a snapshot of the marine food web that existed about 20 million years ago, according to Jack Cooper, a UK-based paleobiologist and megalodon expert who wasn't involved with the study.
'The general picture of megalodon has been of a gigantic shark munching on whales,' Cooper said in an email. 'This study adds a new dimension that megalodon probably had a wide range of prey — essentially, it probably ate not just whales but whatever it wanted.'
Another interesting find, he added, is that megalodon's diet probably varied slightly between different populations, something observed in today's great white sharks. 'This makes sense and is something we would have probably expected since megalodon lived all over the world and not all of its prey items would have done; but it's wonderful to have concrete data supporting this hypothesis,' Cooper said.
The study adds to a growing body of evidence that is reshaping commonly held beliefs about megalodon and its close relatives, said Alberto Collareta, a researcher in the department of Earth sciences at Italy's University of Pisa who was not involved in the research.
'These have led us to abandon traditional reconstruction of the megatooth sharks as 'inflated' versions of the modern white shark. We now know that the Megalodon was something else — in terms of size, shape and ancestry, and of biology, too,' Collareta said via email.
'The Miocene (palaeo)ecosystems in question did not work in a radically different way compared to their modern counterparts — even if they feature … completely extinct protagonists such as the megatooth sharks,' he added, highlighting what he found to be the report's key takeaway.
'That said, it is still useful to acknowledge that our understanding of the Meg is essentially limited to its ubiquitous teeth, a few vertebrae and a handful of scales. What I'd really love to see emerging from 'the foggy ruins of time' is a complete Meg skeleton… Let's hope that the fossil record will amaze us once again.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
an hour ago
- Forbes
Smoking Cessation Aid Cytisinicline Could Soon Get FDA Approval
There are multiple smoking cessation products on the market. But there hasn't been a new approval of ... More a pharmacotherapy without nicotine in nearly 20 years. This could change soon, as cytisinicline was submitted to the FDA for approval on June 26, 2025. More than two-thirds of American smokers say they want to quit. However, besides nicotine replacement therapies, there are at present only two smoking cessation drugs without nicotine that are authorized for marketing by the Food and Drug Administration. This could change soon, as the pharmaceutical firm Achieve Life Sciences submitted to the FDA a new drug application last week for its prescription medicine, cytisinicline, also known as cytisine. The agency will review the medication's efficacy, safety, and tolerability profile based on evidence from two large, placebo-controlled Phase 3 clinical trials. The substance is a naturally occurring plant-based alkaloid that selectively binds to nicotinic receptors in the brain. In turn, this can help alleviate nicotine cravings and reduce withdrawal symptoms, among smokers of combustible cigarettes as well as e-cigarettes (vaping). Cytisinicline has been used as a smoking cessation product for decades in some Central and Eastern European countries. It was approved by the British Medicines and Healthcare products Regulatory Agency in March 2019, though only available commercially in the United Kingdom since January 2024. Cytisinicline hasn't yet been approved by the European Medicines Agency. The Journal of the American Medical Association Internal Medicine published results from one of two Phase 3 trials evaluating cytisinicline for smoking cessation. The authors' conclusions reaffirmed cytisinicline's efficacy and tolerability for smoking cessation in adult smokers at both 6- and 12-week treatment durations, including reduction in nicotine cravings and extended cessation benefits through 24 weeks. Additionally, a study published in 2024 suggested cytisinicline could be effective for e-cigarette cessation. Owing to its mechanism of action as a way to reduce nicotine dependence, it's possible that cytisinicline could be beneficial for individuals using nicotine pouches who wish to stop, though this hasn't yet been examined specifically. Based on a technology assessment of the benefits and costs of cytisinicline, the British cost-effectiveness watchdog, the National Institute for Health and Care Excellence, recommended earlier this year adding the drug to the National Health Service as a treatment option for smoking cessation. And this week, the American Institute for Clinical and Economic Review announced it is conducting an evidence review to assess the clinical effectiveness of cytisinicline together with behavior support. The evaluation will include comparisons with other existing smoking cessation products. Smoking is the leading cause of preventable death in the U.S. Cigarette smoking is responsible for more than 480,000 deaths annually in the U.S. The major causes of death associated with smoking include cardiovascular diseases such as strokes and heart attacks; cancers, among which lung, pancreatic, esophageal, bladder, colorectal and renal; and pulmonary conditions such as chronic obstructive lung disease, pneumonia and bronchitis. Last October, the FDA and the National Institutes of Health convened a public meeting to address the urgency for developing novel smoking cessation products to assist individuals of all ages, including underserved and vulnerable populations, to stop smoking. There is unmet need in this space, reflected in the fact that of the 15 million who tried to quit smoking in 2022, five in six failed, according to STAT News. Experts cite a lack of sufficiently effective smoking cessation drugs. Should cytisinicline become available in the U.S. it could represent an important option for those who wish to quit their nicotine habit. At the same time, it will continue to be critical for healthcare providers and public health authorities to raise awareness around the importance of smoking cessation and prevention, provide behavior support (counseling) and offer treatment alternatives people can use to quit. The U.S. has made real progress since the 1960s in reducing cigarette smoking, mainly through effective public health campaigns. Yet there's still a lot more work to do as roughly 29 million adults smoke combustible cigarettes and approximately 17 million use e-cigarettes. But under the Trump administration the Department of Health and Human Services has cut funding for smoking cessation and prevention programs, as well as eliminated the Centers for Disease Control and Prevention's Office on Smoking and Health. While the CDC says it will continue to provide resources for those who wish to quit smoking while conducting ongoing surveillance, experts warn that cuts in services could limit access, which could then result in a resurgence in smoking rates.
Yahoo
2 hours ago
- Yahoo
Bobby Jenks, former White Sox closer and World Series champion, dies at 44
Bobby Jenks pitched six of his seven MLB seasons with the Chicago White Sox, helping the franchise win the 2005 World Series. (Photo by) Former Chicago White Sox closer Bobby Jenks has died after a battle with Stage 4 adenocarcinoma, a form of stomach cancer. Jenks was 44 years old. The two-time All-Star and 2005 World Series champion revealed his condition during a February 2025 interview with from a hospital bed in Portugal, where he moved to be closer to his wife's family. Jenks spent six of his seven MLB seasons with the White Sox. He posted back-to-back 40-save seasons in 2006 and 2007 and compiled 86 saves over his final three seasons in Chicago. During the 2007 season, he retired 47 consecutive batters. He spent the 2011 season, his last in MLB, with the Boston Red Sox. Advertisement In May 2021, Jenks began working as the pitching coach for the minor-league Grand Junction Rockies. The next season, he was promoted to manager and won the league's Manager of the Year award after helping the team win a championship. Jenks spent the 2023 season as the Princeton WhistlePigs' pitching coach before he returned to managing with the Windy City ThunderBolts later that year. A father of six, Jenks and his wife, Eleni, moved to Portugal in October 2024. Not long after they relocated, he was diagnosed with deep vein thrombosis in his right calf and later dealt with multiple blood clots in his lungs. Early in 2025, he noticed that his energy level was decreasing, and after testing at a local hospital, it was discovered that a tumor had formed in his chest. Advertisement Jenks told that the tumor spread into his stomach lining, his bones, his lower back and his hips. As Jenks was dealing with his health battle, his family was affected by the Palisades fire, which caused them to lose their home and personal belongings, except for his 2005 World Series ring. 'I've got one suitcase left to my name,' Jenks said. 'It's all gone. Everything else I've ever done. I have everything, first to first. All those things are irreplaceable.'
Yahoo
5 hours ago
- Yahoo
Farmers sound the alarm over rapid spread of insect that evolves to eat more crops: 'Further spread ... to other European countries is to be expected'
A new agricultural threat is quickly spreading through Europe, and it's only a few millimeters long, according to Euractiv. Farmers in Germany are raising the alarm about a tiny insect, known as the reed leafhopper, that has evolved to feed on and destroy critical crops like sugar beet and potatoes. Once a harmless resident of wetland reeds, this adaptable pest is now rapidly expanding its range and appetite, with troubling implications for food security and farming across the continent. The reed leafhopper ("Pentastiridius leporinus") is now known to spread a bacterial plant disease called syndrome "basses richesses" (SBR). Different leafhopper variants have also been found in nations like Argentina. The disease significantly reduces crop yields and sugar content, making affected harvests far less valuable. Over 100,000 hectares of farmland in Germany were infested in 2023 alone. Originally found in reed beds and considered harmless, the insect has since adapted to new host plants, including tomatoes, celery, and beetroot. Entomologist Dr. Michael Rostás of the University of Göttingen confirmed the insect's spread and evolution, warning, "Further spread of the leafhopper and the diseases it transmits to other European countries is to be expected." The reed leafhopper's expansion is a growing threat to European agriculture. Because it weakens crops from the inside out, it's hard to detect until the damage is done. As it adapts to more host plants and benefits from warmer conditions, experts believe rising temperatures may be helping it thrive. Farmers face a unique challenge: this new pest is evolving faster than they can keep up with. It can now even survive the winter by living in the roots of cereal crops like wheat, making traditional crop rotation methods less effective. If left unchecked, it could threaten the stability of food supply chains across Europe. Should the government be paying people to hunt invasive species? Definitely Depends on the animal No way Just let people do it for free Click your choice to see results and speak your mind. Germany has issued emergency authorizations for pesticide use in crops to slow the insect's spread. But experts say this is only a stopgap measure. The German Farmers' Association is calling for long-term solutions, including changes to European Union regulations that would allow for new genomic breeding techniques like CRISPR. These methods could help develop crop varieties resistant to the disease the insect carries. Until those tools are approved, farmers will need to rely on careful crop management, timely planting decisions, and community-level monitoring. When it comes to protecting our food supply from fast-moving threats, innovation and cooperation remain our best lines of defense. Join our free newsletter for easy tips to save more and waste less, and don't miss this cool list of easy ways to help yourself while helping the planet.